These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32149134)

  • 1. CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD.
    Peng J; Jiang H; Guo J; Huang J; Yuan Q; Xie J; Xiao K
    Biomed Res Int; 2020; 2020():7638975. PubMed ID: 32149134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.
    Xue YJ; Lu Q; Sun ZX
    Med Oncol; 2011 Dec; 28(4):1363-72. PubMed ID: 20509007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
    Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
    Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.
    Fei F; Li X; Xu L; Li D; Zhang Z; Guo X; Yang H; Chen Z; Xing J
    Ann Surg Oncol; 2014 Dec; 21(13):4359-68. PubMed ID: 25084765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD147 in patients with glioblastoma.
    Yang M; Yuan Y; Zhang H; Yan M; Wang S; Feng F; Ji P; Li Y; Li B; Gao G; Zhao J; Wang L
    J Neurooncol; 2013 Oct; 115(1):19-26. PubMed ID: 23925827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway.
    Yang Y; Liu PY; Bao W; Chen SJ; Wu FS; Zhu PY
    BMC Cancer; 2020 Jan; 20(1):28. PubMed ID: 31924176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer.
    Zhu S; Chu D; Zhang Y; Wang X; Gong L; Han X; Yao L; Lan M; Li Y; Zhang W
    Med Oncol; 2013 Mar; 30(1):369. PubMed ID: 23389916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer].
    Nawroth R; Hartmann A; Wild P; Lehmann J; Stöhr R; Gschwend JE; Retz M
    Pathologe; 2010 Oct; 31 Suppl 2():251-4. PubMed ID: 20661575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins.
    Wang WJ; Chen D; Jiang MZ; Xu B; Li XW; Chu Y; Zhang YJ; Mao R; Liang J; Fan DM
    J Dig Dis; 2018 Feb; 19(2):74-83. PubMed ID: 29314754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma.
    Wu J; Hao ZW; Zhao YX; Yang XM; Tang H; Zhang X; Song F; Sun XX; Wang B; Nan G; Chen ZN; Bian H
    J Transl Med; 2014 Jul; 12():190. PubMed ID: 24996644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1.
    Cai X; Qu L; Yang J; Xu J; Sun L; Wei X; Qu X; Bai T; Guo Z; Zhu Y
    Cancer Med; 2020 Aug; 9(16):6009-6019. PubMed ID: 32627968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.
    Liu XP; Yin XH; Meng XY; Yan XH; Cao Y; Zeng XT; Wang XH
    Medicine (Baltimore); 2018 Sep; 97(39):e11830. PubMed ID: 30278482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
    Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
    Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1/CC chemokine receptor-2 to recruit macrophages.
    Li H; Zhao XK; Cheng YJ; Zhang Q; Wu J; Lu S; Zhang W; Liu Y; Zhou MY; Wang Y; Yang J; Cheng ML
    World J Gastroenterol; 2019 Nov; 25(44):6527-6540. PubMed ID: 31802832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PhospholipaseCγ1/calcium-dependent membranous localization of Gsdmd-N drives endothelial pyroptosis, contributing to lipopolysaccharide-induced fatal outcome.
    Liu H; Tang D; Zhou X; Yang X; Chen AF
    Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1482-H1495. PubMed ID: 33064557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.
    Yu YH; Morales J; Feng L; Lee JJ; El-Naggar AK; Vigneswaran N
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 May; 119(5):553-65. PubMed ID: 25747176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis reveals the expression, genetic alteration and prognosis of pyroptosis key gene GSDMD.
    Qiu S; Hu Y; Dong S
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108270. PubMed ID: 34700129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
    Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
    J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147.
    Wang C; Xu C; Niu R; Hu G; Gu Z; Zhuang Z
    BMC Cancer; 2019 Jun; 19(1):577. PubMed ID: 31196010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSDMD is required for effector CD8
    Xi G; Gao J; Wan B; Zhan P; Xu W; Lv T; Song Y
    Int Immunopharmacol; 2019 Sep; 74():105713. PubMed ID: 31276977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.